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ABSTRACT 
Identification ofNon-Nuclear Receptors for 1,25-dihydroxyvitarnin D3 
in Chick Kidney and Brain 
by 
Zhiheng Jia, Master of Science 
Utah State University, 1998 
Major Professor: Dr. Ilka Nemere 
Department: Nutrition and Food Sciences 
1ll 
1,25-dihydroxyvitarnin D3 (1,25(0H)2D3) has been shown to mediate the rapid, non-
nuclear stimulation of calcium and phosphate transport in chick intestine through binding 
to a receptor localized in the basal lateral membrane. By using an antibody to the N-
terminus of the membrane receptor, studies were undertaken to determine whether a 
comparable protein exists in kidney and brain, and whether it is present in a particular 
subcellular fraction. 
The first step was to establish fractionation protocols to separate subcellular 
organelles as judged by marker enzyme analyses. Differential centrifugation and Percoll 
gradient fractions were prepared from chick kidney and brain whole homogenates by two 
methods (method 1 and method 2). Protein and marker enzymes were analyzed in each 
fraction to determine the distribution of organelles. By method 1, the organelles were not 
adequately separated. By method 2, chick kidney and brain were found to have the same 
IV 
order of organelle distribution: In the post-nuclear pellet (Pz), fraction 1 was found to be 
enriched for the lysosomal marker acid phosphatase; fractions 2-5 were found to be 
enriched for the mitochondrial marker succinate dehydrogenase; fraction 8 was found to 
be enriched for the Golgi marker a-D-mannosidase; and fraction 9 was found to be 
enriched for the plasma membrane marker Na+,K+ ATPase. In Percoll gradients of 
microsomal membranes prepared from the 1 OO,OOOxg pellet (P3), fractions 1-3 contained 
the endoplasmic reticulum marker enzyme activity glucose-6-phosphatase. 
Subsequently, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blots were performed using the antibody to 1,25(0H)2D3 receptors 
in chick intestinal basal lateral membrane. The areas of the bands were scanned by 
computer, and analyzed quantitatively. After establishing a suitable protein concentration 
for Western analysis, differential centrifugation and Percoll gradient fractions were 
analyzed. Finally, the specific binding of eHJ 1 ,25(0H)zD3 was determined in Percoll 
gradient fractions to assess whether the receptor is functional. Plasma membrane 
1 ,25(0H)zD3 receptors were found in both chick kidney and brain cells. Golgi 
membranes also were found to have receptor activity, perhaps since this organelle 
packages proteins for delivery to other membranes. In kidney, fraction Pz 7 demonstrated 
a very high receptor activity, and eHJ 1 ,25(0H)2D3 specific binding assays showed these 
membrane receptors are functional. Although this fraction lacks traditional marker 
enzyme activity, it may contain endocytic vesicles. The physiological function and the 
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CHAPTER I 
INTRODUCTION 
1 ,25-Dihydroxyvitamin D3(1 ,25(0H)2D3) is one of the hormonally active forms of 
vitamin D. This metabolite is generated first by hydroxylation on carbon-25 in the liver 
and then on carbon-1 in the kidney. In addition to its classical role as a major mediator in 
the regulation of calcium homeostasis, it is also involved in many other functions, such as 
regulation of cell growth, and proliferation and differentiation within a wide variety of 
tissues (Simboli-Campbell et al., 1994). 
Over the past 20 years, many studies have provided evidence that 1 ,25(0H)2D3 acts 
through specific nuclear receptor proteins (VDR) (Norman et al., 1992). The hormone-
receptor complexes interact with specific DNA sequences regulating the transcription rate 
of target genes, thus inducing de novo synthesis of mRNAs. The mRNAs are then 
translated into proteins, which, after being processed, are ultimately responsible for the 
biological activity of 1,25(0H)2DJ. One of the best methods to understand the effect of 
1 ,2S(OH)2D3 at the genomic level has been provided by studying the molecular events 
involved in the regulation of the expression of the vitamin D-dependent calcium-binding 
protein (CaBP), termed calbindin-D2sk, which so far is the most extensively studied 
molecular marker; both the gene and protein have been sequenced. The gene spans 18.5 
Kb of chromosomal DNA and is split into 11 coding exons by 10 intervening sequences 
(Theofan and Norman, 1986). 
In spite of the extensive elaboration of evidence supporting the classical nuclear 
receptor hypotheses, there is recent evidence which indicates that the hormone may also 
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affect Ca2+ homeostasis independent of genomic activities . The evidence is as follows: 
(1) In isolated rat intestinal epithelial cells, 1 ,25(0H)zD3 has a direct stimulating effect on 
calcium uptake (Nemere and Szego, 1981a). (2) In vascularly perfused, isolated 
duodenal loops of vitamin D-replete chicks, rapid (within 2-4 min) hormonal 
stimulation of 45Ca transport has been observed; this process is termed transcaltachia, 
and is clearly independent of gene transcription (Nemere et al. , 1984). (3) Effects of 
inhibitors and analogues of 1 ,25(0H)zD3: nuclear transcription inhibitors can inhibit 
nuclear receptor activity, but not transcaltachia (Nemere and Norman, 1987). The Ca2+ 
channel blockers can block transcaltachia, but not nuclear receptors (Norman et al. , 
1992). ( 4) 1 ,25(0H)2D3 conformations and function: different conformations of 
1 ,25(0H)2D3 may preferably bind to different receptors (Nemere et a!., 1994). The 
analogues of 1 ,25(0H)zD3 may be selective agonists or antagonists of genomic or 
nongenomic responses in the vitamin D endocrine system. (5) Purifying and 
characterizing the receptors: it has been reported that the partial purification and 
biochemical characterizations of a putative receptor for 1,25(0H)zD3 from basal lateral 
membrane (BLM) of chick intestinal epithelium has been achieved (Nemere eta!. , 1994). 
The specific objectives of this research were to determine whether the BLM-VD R 
exists in chick kidney (a mineral transporting tissue) and brain (a non-transporting 
tissue). The presence of this receptor in multiple tissues would support the physiological 
importance of this mechanism of steroid hormone action. 
In order to discuss the project results, a brief summary of recent receptor research is 
necessary. Receptors are the focus of a number of different research disciplines. 
Hormones, neurotransmitters, drugs, and antibodies exert their biochemical effects 
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through the initial interaction with specific receptors. The binding of the ligand to its 
specific receptor triggers a cascade of biochemical reactions that eventually leads to the 
final physiological response. Receptor movement is essential for receptor action as well 
as for receptor endocytosis, therefore, both membrane fluidity and the interaction of 
cytoskeleton with the receptor play a part in its function and fate. (Henis and Elson, 1981 ; 
Koppel et al., 1981 ). A typical eukaryotic cell has a variety of different receptors 
distributed on the cell surface. Some of them are randomly distributed on the cell surface 
(Willingham and Pastan, 1982), while others tend to be clustered in specialized 
depressions in the cell membrane that are termed coated pits because of their 
characteristic appearance in the electron microscope (Goldstein et al., 1979). In most 
cultured cells there are 500-1000 coated pits per cell and they occupy about 1% of the 
cell surface. Coated pits are the sites at which ligands and their receptors accumulate as 
the first step of entry into the cell (Pastan and Willingham, 1981 ). After clustering in 
coated pits, ligands begin to appear in uncoated vesicles within the cytosol; these vesicles 
are termed receptosomes or endosomes (Marsh and Helenius, 1980). 
In some cases the formation of receptosomes is probably constitutive and not affected 
by receptor occupancy. That means in the absence of ligands, receptosomes are formed 
just as rapidly as in their presence. Receptosomes are transport vesicles that carry ligands 
and receptors from the cell surface to the cell interior. When first formed, they measure 
about 200 A 0 in diameter, have a low pH (pH 4.5), and do not contain significant 
amounts of functional hydrolytic enzymes (Tycko and Maxfield, 1982; Dickson et al., 
1983). Therefore, ligands and receptors are not extensively degraded. Receptosomes 
move by saltatory motion along tracks of microtubules (Willingham and Pastan, 1980). 
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They eventually come in contact with elements of the trans-Golgi and appear to fuse with 
the Golgi system, delivering their ligands into the lumen of the Golgi system and mixing 
their membrane and its components with the Golgi membrane system (Willingham et a!., 
1984). 
Morphologically, the Golgi has been divided into a series of stacks or cisternae that 
functionally interacts with the endoplasmic reticulum ( cis-Golgi) and a series of 
interconnecting tubules forming a reticular tubular network that does not interact with the 
endoplasmic reticulum (trans-Golgi) . Receptosomes fuse with the tubules of the trans-
Golgi in which sorting of ligand and receptor occurs. The possibilities are: some ligands 
and receptors are returned to the cell surface where the ligand is released back into the 
medium and the receptor can be reutilized (Dantry-Varsat eta!., 1983). Some ligands are 
directed to lysosomes and their receptors returned to the cell surface to be reutilized 
(Salisbury et a!., 1979), and finally some ligands and their receptors are sent on to 
lysosomes to be degraded (Beguinot eta!., 1984 ). 
Transport vesicles need coat proteins in order to form because the coat proteins are 
recruited from the cytosol onto a particular membrane, where they drive vesicle budding 
and select the vesicle cargo. So far three types of coated transports vesicles have been 
purified and characterized: clathrin-coated, COP !-coated, and COP 11-coated vesicles 
(Margweret, 1997). 
The clathrin-coated pit is the unique plasma membrane site at which ligand-receptor 
complexes, destined for endocytosis into the cell, are accumulated and concentrated. 
After ligand-receptor binding, coated vesicles are formed. Coated vesicles are unique 
among membrane-bounded organelles in that they possess a very high protein-lipid ratio 
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and comparatively high particle density (1.22g/ml), yet they were also characterized by 
relatively small sedimentation coefficients (Nossal eta!. , 1983). 
The clathrin is thought to act as a scaffold, self-assembling into a cage-like structure 
which attaches to a membrane, thus enabling the membrane to vesiculate. Protein 
complexes, called adapters, link the clathrin to the membrane. There were two distinct 
types of adapter complexes: AP-1, which is associated with the trans-Golgi network, and 
AP-2, which is associated with the plasma membrane. Clathrin, together with the adapter 
protein complexes, mediates vesicle budding from the trans Golgi network and the 
plasma membrane, respectively. COP I and COP II mediate transport in the early 
secretory pathway. COP I functions as a cytosolic sorter in retrograde transport, COP II 




Vitamin D is essential for life in higher animals. It is one of the most important 
biological regulators of calcium and phosphorus metabolism. 
Historical Background 
The substance vitamin D was discovered in the years between 1919 to 1922. It was 
first identified by Mellanby ( 1919) through nutritional studies, and by McCollum and co-
workers (1922) through the biochemical/chemical studies. These studies established that 
a deficiency state, namely rickets, results from a deficiency of vitamin D, which is a 
nutritionally important fat soluble component. 
Hudschinsky (1919) and Hess and Gutman ( 1922) found that ultraviolet light or 
radiant energy is effective in increasing the degree of calcification of the epiphyses of 
rachitic infants. These studies indicate the presence of an endogenous factor that could be 
converted by UV light into a substance equivalent to the second fat-soluble vitamin. 
From then on for almost 30 years, the area of vitamin D investigation remained in a 
relative state of dormancy. Windaus et al. (1932) provided the chemical characterization 
of the structure of vitamin D2 in 1932, and vitamin D3 in 1936 (Windaus et al., 1936). 
Nicolaysen and Eeg Larsen (1953) found the role of vitamin D in promoting the intestinal 
absorption of calcium. The role of vitamin D in intestine and bone was further clarified 
during the next two decades. It was not until the 1960s that the breakthrough in the 
understanding of vitamin D metabolism occurred, since this era saw the advent of 
preparations of radioactive vitamin D and allowed detection of metabolically active 
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forms (Norman and DeLuca, 1963, 1965). Vitamin D is a prehormone giving rise to a 
number of more polar compounds, some of which have biological activity (Norman and 
DeLuca, 1963, 1965; Norman et a!., 1964). 
Functions of Vitamin D 
Vitamin D, along with parathyroid hormone and calcitonin, is the major substance 
responsible for the maintenance of blood calcium and phosphorus concentration. 
Vitamin D stimulates intestinal calcium absorption under conditions of calcium need 
(Carlsson, 1952; Ribovich and DeLuca, 1975); the mobilization of calcium from bone 
fluid compartment; and the renal reabsorption of calcium in the distal tubule (Sutton and 
Dirks, 1978). 
In addition to its classical role as a major mediator in the regulation of calcium 
homeostasis, vitamin D is equally involved in a number of different cell functions, such 
as regulation of cell growth, and proliferation and differentiation within a wide variety of 
tissues. Most of these actions are far from being understood (Simboli-Campbell et a!., 
1994). 
Metabolism of Vitamin D 
The production of functional metabolites of the vitamin D endocrine system includes: 
photo conversion of ?-dehydrocholesterol to vitamin D3, or dietary intake of vitamin D3; 
metabolism of vitamin D to a family of daughter metabolites, the principal form of 
vitamin D in blood, [25-hydroxyvitamin D3 (25(0H)D3)]; conversion in a physiologically 
regulated fashion of 25(0H)D3 into the two principal dihydroxylated metabolites, 
namely, 1 ,25(0H)2D3 and 24,25(0H)2D3; transport of the dihydroxylated metabolites 
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24,25(0H)2D3 and 1 ,25(0H)2D3 to distal sites of action; and interaction of the 
dihydroxylated metabolites at the principal target organs, namely, the bone, intestine, and 
kidney (Tsai eta!., 1972). 
The chief structural prerequisite of a previtamin D is that it be a sterol with a 6. 5-7 
diene double bond system in ring B. (as show by arrow in Fig. 1). The conjugated double 
bond system in this specific location of the molecule allows the absorption of light quanta 
at certain wave lengths in the UV range, which initiates a complex series of 
transformations that ultimately results in the production of the seco-steroid known as 
previtamin D3. Previtamin D3 is in simple thermoequilibrium with vitamin D3 (Bakker et 
a!. , 1972). The skin has been demonstrated as the site for the sunlight/photo chemical-
mediated photosynthesis of vitamin D3 (Holick, 1981 ). The transport protein for vitamin 
D and its metabolites, known as D-binding protein (DBP), in the blood can transfer the 
A-Ring 
~Side Chain Conformations 
(single bond, conformational rotation 
about 6 bonds) 
~ CD-Ring(a relatively rigid trans-hydrindane 
anchor) 
) 
Seco-B-Ring Triene(s-cis to s-trans 6, 7 
-single bond conformational rotation, 1 ,25 to pre-
1,25 hydrogen shift) 
(chair-chair conformational inversion) 
Figure 1. The dynamic A-ring, seco-B triene, CD ring and side chain of the seco-steroid 
1, 25(0H)2 vitamin D3 
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vitamin D3 from skin to the general circulatory system (Bouillon and Baelen, 1981 ). 
Vitamin D3 is first transferred to the liver where it is hydroxylated on C-25. 25-
Hydroxyvitamin D3 is then transferred to the kidney, where it undergoes further 
metabolism to either 1,25(0H)2D3 or 24,25(0H)2D3 (Norman et al., 1971). The regulators 
of renal vitamin D hydroxylyses include: parathyroid hormone (PTH) (Booth et al., 
1977), calcitonin (Kawashima et al., 1981), vitamin D status (Henry et al. , 1974), serum 
calcium and phosphorus (Hughes et al., 1975), and perhaps others. Even though it is now 
widely accepted that kidney is the principal endocrine gland that produces 1 ,25(0H)2D3 
and 24,25(0H)2D3, it has also been demonstrated that a number of other tissues, such as 
intestine, placenta, and bone, have 25(0H)D3 !-hydroxylase and 24-hydroxylase and 
produce several less active metabolites. So far about 37 separate metabolites have been 
found (Okamura et al., 1995). 
Mechanism of Vitamin D Biological Actions 
Many lines of evidence have shown that 1 ,25(0H)2D3 is the most biologically active 
form of vitamin D. It can stimulate the biosynthesis of components of the calcium 
transport pathway by genomic regulation, and it also has a direct stimulating effect on 
calcium uptake in intestinal epithelial cells by non-nuclear regulation. 
Genomic Actions of 1,25(0H)2D3 in Intestine 
Over the past 20 years, studies from many labs have provided evidence that 
1 ,25(0H)2D3 acts as a steroid hormone by way of a specific nuclear receptor protein 
(VDR), which is a member of the steroid and thyroid/retinoid receptor superfamily of 
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ligand-dependent transcriptional regulators (Hining et a!., 1988). The hormone-receptor 
complex is thought to interact with specific DNA sequences regulating the transcription 
rate of target genes and thus inducing de novo synthesis of mRNA species. These 
mRNAs are then translated into proteins, which after being processed, are ultimately 
responsible for the biological activity of 1,25(0HhDJ. Today, some 28 tissues as well as 
many cell lines have been shown to possess the 1 ,25(0H)2D3 nuclear receptors (Norman 
eta!., 1992). The nuclear 1 ,2S(OH)2D3 receptor is a DNA- binding protein capable of up-
regulating or down-regulating the transcription of specific RNA polymerase II-
transcribed genes. Baker et a!. (1988) have proposed that the DNA-binding loops are 
zinc fingers in the avian and human receptors. A well studied vitamin D target organ is 
the intestine. In intestine, the nuclear receptor for 1 ,25(0H)2D3 mediates the biosynthesis 
of a vitamin D-dependent calcium-binding protein (CaBP), termed calbindin-D2sk, which 
binds Ca2+ with high affinity (Kd= 1 o-8 M; Corradino and Wasserman, 1968; Minghetti 
and Norman, 1988). 
The deduced amino acid sequence of the eDNA clones coding for the 1 ,25(0H)2D3 
receptor shows the presence of cysteine-, lysine-, and arginine-rich regions, which 
display a high degree of homology with other members of the steroid receptor family 
(McDonnell eta!., 1987). It has therefore been proposed that this highly conserved region 
could constitute the DNA binding domain of these proteins. The human and chick 
1 ,25(0H)2D3 receptors have been cloned; they are proteins of approximately 50 KD and 
have structural homology to the superfamily of nuclear steroid hormone receptors 
(Haussler, 1986). 
11 
The gene for calbindin-D2sk also has been cloned and sequenced and it spans 18.5 Kb 
of chromosomal DNA and is split into 11 coding exons by 10 intervening sequences 
(Theofan and Norman, 1986). The 1 ,25(0H)2D3 receptors are proposed to regulate four 
classes of genes including those associated with: (a) a differentiation pathway, (b) a 
proliferation pathway, (c) a developmental pathway, and (d) calcium and phosphorus 
homeostasis (Norman et al., 1984). 
Nongenomic Actions of 1 ,2S(OH)2D3 
in Intestine 
In spite of the extensive elaboration of evidence supporting the classical nuclear 
receptor hypothesis for 1 ,25(0H)2D3, there are a number of recent studies which question 
whether all the actions of 1,25(0H)2D3 can be explained by this simple model. An 
increasing body of evidence indicates that the hormone may also affect Ca
2
+ homeostasis 
independently of genomic activities. The evidence can be summarized as follows. 
Rapid Actions of 1 ,25(0H)2D:l 
As 1 ,25(0H)2D3 nuclear action results in de novo protein synthesis, the process 
requires several hours lag time after 1 ,2S(OH)2D3 administration: 60 min for CaBP 
mRNA synthesis, 6-8 h for Ca2+ transport. In 1981, a direct, rapid effect on intestinal 
cells isolated from normal vitamin D rats was found, as determined by calcium uptake 
and lysosomal enzyme release (Nemere and Szego, 1981 b). In 1984, vitamin D replete 
chicks were used to study transport since the equivalent status allowed the detection of 
the rapid effects of 1,25(0H)2D3 (Nemere et al., 1984). Using vascularly perfused, 
isolated duodenal loops, in which 45 Ca was instilled in the lumen, collection of the 
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venous effluent for the determination of radioactivity yielded an analysis of net calcium 
transport in such preparations. The salient findings were that presentation of 130 pM 
1,25(0H)
2
D3 to the basal lateral membrane, by way of vascular perfusion, resulted in the 
rapid (within 2-4 min) hormonal stimulation of 
45
Ca transport (Nemere and Norman, 
1986). This rapid 1 ,25(0H)2D3-mediated transport of calcium has been termed 
transcaltachia and is clearly independent of the gene transcription effect of 1 ,25(0H)2D3. 
Since then, rapid effects of 1 ,25(0H)2D3 have been reported in many tissues and cell 
lines , such as kidney (Bourdeau et al., 1990), rat-derived osteoblast-like Ros 17/2.8 cells 
(Caffrey and Farach-Carson, 1989), pancreatic ~-cells (Sergeev and Rhoten, 1995), and 
rabbit iliac epithelial cells (Nasr et al., 1988). In a pancreatic ~-cell line, 1 ,25(0H)2D3 (2-
20 nM) rapidly (within 5-10 sec) increased [Ca2+i] uptake and evoked sinusoidal [Ca
2
+i] 
oscillations. In enterocytes, increased phosphate uptake was evident within 20 min (Nasr 
et a!. , 1988). In Ros 17/2.8 cells, membrane potential was altered within seconds 
(Farach-Carson et al. , 1991 ). Alkaline phosphatase activity (APA) was significantly 
increased when intestines were perfused with 3 nM 1,25(0H)2D3 for 30, 45, or 60 min 
(Bachelet et al., 1979); it was found to be a dose-dependent and time-dependent 
response. Moog et al. (1972) have shown that in mouse and chick intestine the amount of 
phosphate absorbed into the tissue is proportional to the AP A. It is possible that the 
increase in phosphorus accumulation by cultured chick ileum explants in response to 
1 ,25(0H)2D3 is somehow related to the early APA stimulation. 
Inhibitors 
Perfusion studies have been designed to test the effects of various inhibitors on 
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calcium transfer in intestine (Nemere and Norman., 1987). Table 1 summarizes the results 
of the inhibitor studies: transcaltachia was inhibited by the anti-microtubule agent 
colchicine, an antagonist of lysosomal cathepsin B, leupeptin, and the Ca2+ channel 
blockers verapamil and nifedipine (Norman et a!., 1992). The nuclear transcription 
inhibitor, actinomycin D, inhibits nuclear receptor activity, but not transcaltachia. The 
microfilament inhibitor cytochalasin B did not block transcaltachia induced by 
1 ,25(0H)2D3, whereas the microtubule-disrupting agent, colchicine did (Nemere and 
Norman, 1987). 
The Ca2+ -channel agonist BAY K8644 can mimic the effect of the sterol on the 
transcaltachic response (de Boland et a!., 1990). Enhanced calcium transport was 
observed when the BLM surface was exposed by vascular perfusion with BAY K8644, 
increasing to greater than 70% over control values within 2 min and 200% after 3 min. 
This suggests that the activation of BLM voltage-regulated Ca2+ -channels is involved in 
transcaltachia (de Boland eta!., 1990). 
Analogues of 1 ,25(0H)2D3 may be synthesized as selective agonists or antagonists of 
genomic or nongenomic responses in the vitamin D endocrine system (Norman et al., 
1993). Several analogues (25-hydroxy-16-ene-23-yne-vitamin D3 and 25-hydroxy-23-
yne-vitamin D3) were found to stimulate Ca
2
+ channel opening, but bind only poorly to 
the 1 ,25(0H)2D3 nuclear receptors. Conversely, other analogues (1 ,24-dihydroxy-22-ene-
24-cyclopropylvitamin D3, 1,25-dihydroxy-16-ene-23-yne-vitamin D3 and 26, 27 F6-
vitamin D3) bound very well to the nuclear receptors but displayed little or no activity in 
opening Ca2+ channels. These results indicate that there may be distinct nuclear and 
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Table 1. Identification of inhibitor transcaltachia (Norman eta!. , 1992) 
Inhibition of 
Components Inhibits Transcaltachia 
Actinomycin D Nuclear Transcription No 
Leupeptin Cathepsin B Yes 
Pepstatin Cathepsin D, Pepsin No 
Monensin Golgi No 
Colchicine M icrotu bu les Yes 
Cytochalasin B Microfilaments No 
Verapamil Ca2+ channel antagonist Yes 
Nifedipine Ca2+ channel antagonist Yes 
Staurosporine Protein Kinase C Yes 
plasma membrane-associated forms that are involved in genomtc and nongenomic 
activation (V anham et a!. , 1988). The A ring of the analog dihydroxy-22-ene-24-
cyclopropylvitamin D3 contains two hydroxyls, namely, the 3 -and 1 -hydroxyl groups, 
which have been shown to be essential for binding to the nuclear 1 ,25(0H)20 3 receptors, 
so both 3-deoxy-1 ,25-(0H)2D3 and 25-(0H)D3 bind poorly to nuclear receptors (Norman 
eta!., 1993; Curtin and Okamura, 1991 ). 
1 ,25(0H)2DJ. Conformations and Functions 
It is convenient to subdivide the structurally dynamic steroid 1 ,25(0H)2D3 into four 
distinct "geographic regions" (Fig. 1 ): the A ring exists as an equilibrating pair of chair 
conformations; the seco-B-ring triene may exist in the limiting 6-s-trans and less stable 6-
s-cis forms by 6,7-single bond rotation; the relatively rigid CD ring, a trans-hydrindane 
unit which is assumed to be a chair; and finally the side chain, which is virtually free to 
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rotate about six single bonds (Okamura eta!., 1995). 1 ,25(0H)2D3 is a structurally unique 
steroid hormone because it possesses a seco-B triene structure (it lacks a B-ring and is 
usually depicted in a nonsteroidal, extended conformation). These structures render the 
seco-B steroid 1 ,25(0H)2D3 considerably more conformationally flexible. 
Since 1 ,25(0H)2D3 is now known to target a myriad of tissues where specific 
interactions occur to produce an array of biological responses, it is proposed that different 
topologies of the seco-steroid (resulting from different conformational orientations of 
1 ,25(0H)2D3) are necessary to interact effectively at the different target sites. The array 
of biological responses includes both nongenomic and genomic effects. For the non-
genomic calcium transport response of transcaltachia, the biological results obtained for 
pre-1 ,25(0H)2D3 analogues point strongly to the involvement of the 6-s-cis conformer of 
1,25(0H)2D3 (Dormanen eta!., 1994); this represents a clear case of biological action 
occurring by way of a stable ground state conformer. For the genomic response, the 6-s-
cis conformer apparently is not recognized by the nuclear 1 ,25(0H)2D3-receptor (Nemere 
et a!., 1994). For other genomic (or nongenomic) effects, there is no clear evidence 
whether the steroidal (6-s-cis) or nonsteroidal (trans) conformer of 1,25(0H)2D3 is 
involved. 
Two closed Bring steroid analogues of 1,25(0H)2D3, 1,25(0H)2-7-dehydrocholesterol 
and 1 ,25(0H)2-lumisterol were able to generate the nongenomic response, transcaltachia, 
without the ability to bind to nuclear receptors. So it is proposed that the nongenomic, 
membrane-associated receptor can accept the ligand in its closed "6-s-cis" conformation, 
whereas the nuclear receptor prefers the extended "6-s-trans" conformer. 
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Purifying and Characterizing the Receptors 
Recently Nemere eta!., (1994) have reported for the first time the partial purification 
and biochemical characterization of a putative receptor for 1 ,25(0H)2D3 from basal 
lateral membranes (BLM) of chick intestinal epithelium, which is involved in the signal 
transduction process associated with transcaltachia. A 4500-fold purification of the BLM-
VDR was achieved. The detergent solubilized BLM-VDR exhibits a specific and 
saturable binding for eHJ1,25(0H)2D3 with a Ko=0.72 10·9 M, Bmax=0.24 pmols/mg of 
protein. The BLM-VDR is composed of 1-3 proteins with molecular weight 
approximately 66,000 D. Functional correlations between the binding activity and 
transcaltachia were made. Recently, the N-terminal 20 amino acids of the BLM-VDR 
have been sequenced, and a synthetic peptide of equivalent sequence was subsequently 
used to raise polyclonal antibodies in rabbits (Biotechnology Center, Utah State 
University) . The antibody has been demonstrated to react with a single band of 64 KD on 
Western analysis; a band of equivalent molecular weight was found to be labeled by the 
affinity reagent [14C] 1 ,25(0H)2D3-bromoacetate (Nemere eta!. , 1997). 
The kidney is also a calcium-transporting tissue. By using immunoperoxidase and 
immunofluorescence techniques, the distribution of CaBP in the chick kidney has been 
determined, suggesting that 1 ,25(0H)2D3 has genomic actions in renal cells. Brain is not 
a calcium-transporting tissue, but it was reported that 1 ,25(0H)2D3 nuclear receptors 
were in rat and chick brain (Haussler, 1986). Whether or not the non-nuclear receptors 
are in kidney or brain has not been investigated. The goal of this research project was to 
determine whether non-nuclear 1 ,25(0H)2D3 receptors are also in the kidney and brain. 
CHAPTER III 
MATERIALS AND METHODS 
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The objectives of this project are to use a polyclonal antibody that reacts with theN-
terminal sequence of the 1,25(0H)203 receptor of basal lateral membranes to see if the 
receptors are in chick kidney and brain, and if so, to identify the subcellular location of 
the receptors. 
Differential and Percell gradient centrifugation fractions were prepared from chicken 
kidney homogenates, and then analyzed for protein and marker enzymes, to determine 
the distribution of organelles. · Subsequently, SDS-PAGE and Western blots were 
performed using the antibody to 1 ,25(0H)203 receptors of intestinal basal lateral 
membranes. The Western blots were scanned into a computer file and then analyzed 
quantitatively by densitometry to determine which fractions contained the highest relative 
receptor activity, allowing the organelle location of the receptors to be decided. Finally, 
specific binding assays of eH] 1 ,25(0H)203 were performed to see if the receptors are 
functional. 
Animals and Tissue Removal 
White leghorn cockerels were obtained on the day of hatching and raised for 3-6 
weeks, on a commercially available vitamin D-replete diet (Nemere, 1996). After being 
anesthetized with chloropent (0.3ml/1 OOg body weight), the chicks were killed by 
decapitation, then the kidneys and brain were taken out quickly and put in 
homogenization medium on ice. 
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Subcellular Fractionation 
A combination of differential and Percoll-gradient centrifugation was used for 
subcellular fractionation. The procedure is illustrated in Figs. 2-5 . 
Method 1 and Method 2 Subcellular 
Fractionation for Kidney Samples 
The isolated kidneys were minced into small pieces in ice cold homogenization buffer 
1 or 2 (20: 1, v/w; Sacktor et al., 1981 ). Buffer 1 was composed of 0.25M sucrose buffer 
: 0.25 M sucrose, 10 mM Tris, pH 7.6 for method 1, and buffer 2 contained 0.25 M 
sucrose, 5mM histine : imidazole, 2 mM EGTA, pH 7.0 for method 2. Homogenization 
P, 
(nuclei) 
Po (whole homogenate) 








100,000 X g, 
60 min 
p3 (microsomes) . s3 
Percoll gradient Centrifugation 
Figure 2. Protocol for preparation of differential centrifugation fractions from kidney 
whole homogenate. 
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was then performed by hand (60 up-and-down strokes in a Potter-Elvejhem homogenizer 
fitted with a Teflon pestle), and differential centrifugation fractions were prepared as 
follows (Sacktor et al., 1981 ): The whole homogenate (Po) was centrifuged at 700 x g, 10 
min (4°C). The pellet fraction (P 1) was saved for analysis, while the supernatant fraction 
(SJ) was centrifuged at 24,000 X g, 20 min to yield P2 and S2. The supernatant fraction 
(S2) was subjected to high speed centrifugation (1 00,000 X g, 1 h) to yield P3 
(microsomes) and S3 (cytosol). Separation of components in P2 or P3 was achieved by 
Percoll gradient centrifugation. 
Resuspended in 32.2 ml buffer 4 (brain; 
see materials and methods) or 
buffer 1 (kidney), resuspended 
with 30 strokes (kidney), or 25 strokes 
(brain). Then 2.8 ml of 100% Percoll 
was added, mixed and centrifuged at 
30,000 x g, 35 min. 
Percoll pradient 
Collect 1 ot drop fractions 
Diluted with 4 vol of buffer 3, 
entrifuge 34,000 x g, 30 min 
Remove percoll 
+ 
SDS-PAGE and Western blot 
Analyze for protein and 
marker enzymes 
Figure 3. Preparation of Percoll gradient centrifugation fractions from kidney or brain 
by method 1. 
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The conditions for Percoll gradient centrifugation compared the method of Sacktor 
et al. (1981; method 1) with that ofNemere et al. (1986; method 2). Variables included 
the extent of homogenization to achieve resuspension of P2 or P3, the final concentration 
of Percoll, and the centrifugation conditions. 
In the method of Sacktor et a!. ( 1981 ), pellets of P2 or P3 were resuspended in 32.2 
ml buffer 1 with 30 strokes in a Potter-Elvejhem homogenizer after which 2.8 mls of 
100% Percoll was added and the suspension mixed vigorously. The suspension was 
Po (whole homogenate) 
j1000 x g, 10 min .. 
Nuclear pellet 
Wash with 
buffer 4 (method 1) or 
buffer 2 (method 2) 
once, then centrifuge 




1000 x g, 10 min 
~ 
1 OO,OOOxg, 1 h (method2) Wash 3 times with 
Buffer 4 (method 1) or 
Buffer 2 (method 2), 
3 centrifuge at 1 O,OOOxg, 
20 min. 
P 11 d. fu erco gra 1ent centn gatlon 
Figure 4. Protocol for preparation of differential centrifugation fractions from brain 
whole homogenate. 
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centrifuged at 30,000 X g for 35 min. Fractions were then collected and diluted at least 
4-fold with buffer 3 containing I 00 mM KCL, I 00 mM mannitol, 5 mM Hepes-Tris, pH 
7.2, and centrifuged at 34,000 X g for 30 min to remove the Percoll. 
In the method ofNemere et al. (1986), P2 or P3 pellet fractions were resuspended in 
25 ml of Percoll solution (21.85% Percoll, 0.25 M sucrose, 5 mM histidine : imidazole, 2 
mM EGTA, pH 7.0, starting density= 1.06 g/ml), resuspended in a Potter-Elvejhem 
homogenizer with 6 strokes, and then transfered to polycarbonate centrifugation tubes 
Resuspended in 25 ml Percoll solution 
(see materials and methods), 
with 6 strokes, overlayed on 2 ml of 
2.4 M sucrose, centrifuged at 
30,000 x g, 45 min. 
Percoll radient 
Collect I 00 drop fractions 
1· Diluted 10 fold in bu fer 4, 
t Centrifuge at 25,000 x g, 60 min. 
Remove Percoll • SDS-PAGE and Western blot 
Analyze for rotein and 
marker enzymes 
Figure 5. Preparation of Percoll gradient centrifugation fractions in kidney or brain by 
method 2. 
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containing 2 ml cushions consisting of 2.4 M sucrose. The suspensions were centrifuged 
for 45 min at 30,000 X g in a 60 Ti rotor (Beckman Instruments, Fullerton, CA). The 
fractions were then collected and diluted at least 10-fold in buffer 2 , and then centrifuged 
at 25,000 X g for 60 min to remove the Percoll. 
One hundred-drop fractions were collected from each gradient for protein and marker 
enzyme analysis. For SDS-PAGE, Percoll was removed by diluting each fraction in 
medium and then centrifugation. The supernatants were carefully aspirated and the pellet 
containing subcellular material was removed from the firmer Percoll pellet. 
Method 1 and Method 2 Subcellular 
Fractionation for Brain Samples 
The isolated brains were minced into small pieces in ice cold homogenization buffer 
4 (0 .32 M sucrose) for method 1 or in ice cold buffer 2 for method 2 (1 0 ml I brain, Gurd 
et a!., 1973). Homogenization was performed by hand (50 up-and-down strokes in a 
Potter-Elvejhem homogenizer fitted with a Teflon pestle), differential centrifugation 
fractions were prepared as follows (Gurd eta!., 1974) : The whole homogenate (Po) was 
centrifuged at 1000 x g, for 1 0 min ( 4 °C), The nuclear pellet was washed once and the 
supernatant was centrifuged at 1000 x g for 10 min again, then the combined supernatant 
fractions (S 1) were centrifuged at 10,000 x g for 20 min to yield the crude mitochondrial 
pellet (P2). The pellet fraction P 1 was saved for analysis. P2 was washed three· times by 
resuspending in buffer 4 for method 1, buffer 2 for method 2, and centrifuged at 10,000 x 
g for 20 min. For method 1, the supernatant fraction (S2) was saved for analysis. For 
method 2, S2 was subjected to high speed centrifugation (1 00,000 x g, 60 min) to yield 
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pellet fraction (P3) and supernatant fraction (S3). Separation of Pz (method 1) or P2 and P3 
(method 2) was achieved by Percell gradient centrifugation. Percell gradient 
centrifugation studies compared method 1 (Sacktor et al., 1981) with method 2 (Nemere 
et a!. , 1986). Variables included the extent of homogenization to achieve resuspension of 
Pz or P3 , the final concentration of Percell and the centrifugation conditions. 
In method 1, pellets of P2 or P3 were resuspended in 32.2 ml buffer 4 with 25 strokes 
in a Potter-Elvejhem homogenizer, then 2.8 ml of 100% Percell was added and the 
suspension mixed throughly. The suspension was centrifuged at 30,000 x g for 35 min. 
Fractions were collected and diluted at least 4-fold with buffer 3 and centrifuged at 
34,000 x g for 30 min to remove the Percell. 
In method 2, the procedure for Percell gradient centrifugation was the same as that of 
kidney by method 2. 
One-hundred-drop fractions were collected from each gradient for analysis of protein 
and marker enzymes. Percell was removed by diluting each fraction in buffer 4, then 
centrifuged at 25,000 x g, 60 min. The samples removed from Percell were used for 
SDS-PAGE and Western blot analysis. 
Marker Enzyme Assay 
Acid phosphatase activity was used as the marker enzyme of lysosomes. Acid 
phosphatase activity was assayed in 0.1 M citrate buffer, pH 5.2, using p-nitrophenyl 
phosphate as substrate, according to Nemere et al. (1986). 
Succinate dehydrogenase (SDH) activity was determined as the marker enzyme 
activity for mitochondria, using the procedures of Pennington eta!. (1961 ). 
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Na +,K+ ATPase activity was assessed as the marker enzyme activity of plasma 
membrane, using the method of Mircheff and Wright (1976). 
Glucose-6-phosphatase activity was analyzed as the enzyme marker of endoplasmic 
reticulum. The enzyme was assayed by the method of Hubscher and West (1965). 
a-D-mannosidase activity, a marker enzyme of lysosomes and Golgi apparatus, was 
assayed by the method ofDoulat eta!. (1977). 
Protein was determind by the Bio-rad reagent using bovine gamma globulin as 
standard. 
SDS-PAGE and Western Blot 
Subcellular fractions were resolved on sodium dodecyl sulfate (SDS) polyacrylamide 
gels according to the method of Laemmli (1970). Colored molecular weight standards 
were run simultaneously to monitor the subsequent transfer of protein to PVDF 
membranes by electroblotting. 
The 1,25(0H)2D3 BLM-VDR has been purified by a combination of anion-exchange 
and gel filtration FPLC (Nemere et a!., 1994). Upon SDS-PAGE and silver staining, a 
protein of molecular weight 66,000 was observed to correlate with the fraction containing 
1 ,2S(OH)2D3 binding. This protein has been N-terminally microsequenced to 20 residues. 
So far, no substantial homology has been found with other proteins within the Swissprot 
computerized database (Nemere, personal communication). The N-terminal 
micro sequence of the protein has been used for synthesis of an analogous peptide, which 
was used to raise a polyclonal antibody. The antibody has been characterized by Western 
analysis and immunofluoescence microscopy (Nemere eta!., 1997). 
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After electrophoresis, the SDS polyacrylamide gels were placed in the transfer buffer 
(25 mM Tris, 192 mM glycine, 15% methanol) to equilibrate for 15-20 minutes. 
Immobilon-P membranes, cut to fit the SDS gel, were wetted in 5-10 ml of 100% 
methanol for 1-2 sec and then placed in 500 ml distilled, deionized water for 5 min, then 
in 500 ml transfer buffer for 10-15 min. Electrob1otting was performed at 10 V (volts) 
for 13 h in the cold room ( 4°C). Transfer was monitored by the migration of colored 
molecular weight standards. 
Western analyses were performed by the Millipore protocols (Millipore, 1990). For 
Western analysis, the membrane containing electroblotted proteins was incubated for 1 h 
at 37°C in 100 ml blocking buffer (150 mM NaCI, 10 mM sodium phosphate, adjusted to 
pH 7.4, with 0.5% (w/v) non-fat milk powder). The membrane was washed 3 times for 5 
min each in washing solution (0.1 %BSA w/v in Tris buffered saline (TBS): 150 mM 
NaCl, 20mM Tris, 0.02% NaN3). The membrane was incubated for 2 h at room 
temperature in antibody incubation solution (1% w/v BSA, 0.05% v/v Tween-20 in TBS) 
containing primary antibody diluted at 1:5000. The membranes were again washed 3 
times for 5 min each, and transfered to antibody incubation solution containing alkaline 
phosphatase-conjugated secondary antibody diluted at 1:30,000. After a 2-h incubation at 
room temperature, 3 additional washes were performed. For visualization, the membrane 
was incubated with chromogenic substrate, BCIP (5-bromo-4-chloro-3-indolyl 
phosphate) and NBT (nitro blue tetrazolium). For each 10 ml of alkaline phosphatase 
buffer (100 mM NaCl, 100 mM Tris, pH 9.5) 33 )ll BCIP (O.lg in 2 ml of 100% dimethyl 
formamide) and 66 )ll NBT (0.25g in 5 ml of 70% dimethyl formamide) were added. 
The colored reaction product was allowed to develop for 30 min at room temperature. 
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Protein dependence of the sample in yielding the final colored reaction product was 
determined first. Then, using a protein concentration below maximal color development, 
subcellular fractions were analyzed. 
Quantitation of Western Blots 
Western blots were scanned into a computer file and densitometrically analyzed using 
Dendron software. The band area of each fraction was related to Po (whole homogenate) 
to normalize for differences in color development between experiments. 
Analysis ofSpeci.fic tHJ 1,25(0H)2DJ 
Binding 
To corroborate the results of the Western analyses, fractions were analyzed for 
specific eHJ 1 ,25(0H)2D3 binding. Because membrane receptors exhibit a low level of 
binding with the hydroxylapatite assay using the protocol of Wecksler and Norman 
(1979), specific binding was determined by the perchloric acid method (Nemere et al., 
1994). All incubations contained 200-)..l.l samples in a Tris buffer and 20 ).ll of an 
ethanolic solution containing either tritiated metabolite alone to determine total binding, 
or 20 ).ll of tritiated metabolite plus a 200-fold molar excess of nonradioactive metabolite 
to determine nonspecific binding. The final concentration of ethanol was 10% v/v in the 
assay. Each sample was normally assayed in triplicate for total binding, and duplicate for 
nonspecific binding. All incubations were conducted at 0°C overnight prior to separation 
of bound and free metabolites by perchloric acid precipitation. In this method, perchloric 
acid and carrier protein (bovine-y-globulin) were added to each tube to yield final 
concentrations of 325 mM HCL04 and 152 ).lg of y-globulin. The mixture was incubated 
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on ice for 30 min, and the precipitated protein pelleted at 10,000 rpm in a microcentrifuge 
rotor (5 min, 4°C). The supernatant fractions were decanted and the inside of the tube 
carefully swabbed. The pellets, which contain the seco-steroid binding moiety, were 
solubilized in the presence of 6M guanidine HCl and pipetted into scintillation vials. Six 
milliliters of Aquasol (New England Nuclear) was added to each vial for liquid 
scintillation spectrophotometry. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Distribution of Marker Enzyme Activities in 
Kidney Fractions Prepared by Method 1 
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Figure 6 illustrates the distribution of marker enzyme activities and protein m 
differential centrifugation fractions of kidney prepared by method 1. The specific 
activities of acid phosphatase, succinate dehydrogenase, and Na +, K+ ATPase were all 
enriched in fraction P2, 1.69-, 2.16-, and 5.57-fold, relative to corresponding values in 
whole homogenates. In comparison, glucose-6-phosphatase specific activity was enriched 
5.37-fold in fraction P3, relative to whole homogenatres. 
Figure 7 depicts the distribution of these marker enzyme activities m Percoll 
gradients. Acid phosphatase activity was enriched approximately 2-fold in all gradient 
fractions of P2 (Fig. 7 A), indicating inadequate separation of lysosomes from other 
organelles. The lack of resolution could be due to disruption of organelles during 
resuspension or insufficient gradient density. Acid phosphatase activity was not enriched 
in any gradient fraction of P3, relative to whole homogenates (Fig. 7 A). Succinate 
dehydrogenase activity exhibited a peak of activity in fraction 1 (Fig. 7B) and was 
enriched 5-fold relative to whole homogenates. Na +, K+ ATPase activity was enriched 
15-fold in fraction 8 and 10-fold in fraction 9 in P2 Percoll gradients, while no enrichment 
was observed in P3 Percoll gradient fractions (Fig. 7C). Glucose-6-phosphatase activity, 
the only marker enzyme enriched in fraction P3, revealed a 9-fold increase in specific 
activity in Percoll gradient fraction P3, 1, relative to whole homogenates. A substantial 
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Figure 6. Distribution of enzyme activities in kidney differential centrifugation fractions 
prepared by method 1. Differential centrifugation fractions were prepared by the 
procedures described in Fig. 2. Values represent the mean ± SEM, for the specific 
activities of(A) acid phosphatase (n=3); (B) succinate dehydrogenase (n=3); (C) Na+,K+ 
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Figure 7. Distribution of enzyme activities in kidney Percoll gradient fractions of P2 and 
P3 (except succinate dehydrogenase) prepared by method 1. Percoll gradient fractions 
were prepared by the procedures described in Fig. 3. Values represent the mean± SEM, 
for (A) acid phosphatase specific activity (n=3); (B) succinate dehydrogenase specific 
activity (n=3); (C) Na +,K+ ATPase specific activity (n=4); (D) glucose-6-phosphatase 
specific activity (n=3). Panel E indicates the results of protein distribution (n=5). 
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enrichment of the endoplasmic reticulum marker was also found in fractions P3, 2 and 
Protein analyses revealed the highest levels in fraction P2, 1 (Fig. 7E). 
The data presented in Figs. 6 and 7 are numerically summarized in Table 2. 
Recovery of marker enzyme activities in differential centrifugation fractions was 
found to be 72-90% of initial levels (Table 3), approximately 80% of each activity was 
recovered in Percoll gradient fractions, relative to levels in the starting pellet fraction (P2 
Distribution of Marker Enzyme Activities 
in Kidney Fractions Prepared by Method 2 
In view of the results of differential centrifugation fraction enzyme assays obtained 
by method 1, P3 Percoll gradient fractions were only assayed for glucose-6-phosphatase 
in method 2. 
Figure 8 shows the distribution of marker enzyme activities and protein in differential 
centrifugation fractions of kidney prepared by method 2. Acid phosphatase and succinate 
dehydrogenase activities were both enriched over 2-fold in P2, relative to corresponding 
activities in whole homogenate. The mitochondrial marker alpha-D-mannosidase was 
enriched approximately 2-fold in P2, although an equivalent level was observed to be in 
the supernatant fraction S2. The basal lateral membrane marker activity was slightly 
higher in P2 (2.07-fold) than in Pr (1.93-fold), relative to whole homogenates. Glucose-6-
phosphatase activity was enriched to a greater extent in P3 (4.85-fold) than in P2 (3.66-
fold), relative to whole homogenates. Once again, protein was highest in whole 
homogenates and the low-speed pellet PI· 
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Table 2. the enrichment of enzyme activities in kidney fractions prepared by method 1 a 
Acid Succinate Na+,K + ATPase Glucose-6-Phosphatase 
Phosphatase Dehydrogenase 
P, 0.83 ± 0.11 1.47 ± 0.47 1.58 ± 0.62 0.62 ± 0.24 
p2b 1.69 ± 0.13 2.16±0.73 5.57±2.81 3.47 ± 0.97 
p)b 0.83 ± 0.09 0.77 ± 0.30 2.08 ± 0.92 5.37 ± 1.56 
s,b 1.11 ± 0.08 0.42±0.17 0.76 ± 0.92 0.97 ± 0.21 
s} 0.62 ± 0.18 0.29±0.10 0.21±0.10 0.80 ± 0.08 
S/ 0.56 ± .050 0.89 ± 0.36 0.27 ± 0.09 0.54 ± 0.08 
P2, 1 c 2.34 ± 0.41 5.44 ± 2.54 0.78 ± 0.35 4.63 ± 1.55 
2 2.37 ± 0.21 1.00 ± 0.33 4.81±2.16 4.04± 1.12 
3 2.68 ± 2.24 0.54±0.19 4.95 ± 2.87 3.35 ± 1.30 
4 2.58 ± 0.32 0.70 ± 0.20 6.33 ± 3.04 4.93 ± 1.68 
5 2.37 ± 0.28 0.76 ± 0.31 5.12±2.87 5.34±2.10 
6 2.53 ± 0.16 0.69 ± 0.50 7.01 ±3 .57 5.34 ± 1.67 
7 2.98 ± 0.43 0.64 ± 0.49 7.57 ± 3.72 4.61 ± 1.67 
8 2.67 ± 0.30 0.48 ± 0.23 15.48± 6.65 3.62 ± 0.85 
9 2.51 ± 0.39 0.85 ± 0.27 10.00± 4.25 2.26 ± 0.94 
P3, 1 d 1.27±0.16 0.54 ± 0.24 8.97 ± 2.42 
2 1.65 ± 0.27 0.81 ± 0.32 7.24 ± 1.73 
3 1.30 ± 0.18 1.78 ± 0.45 7.35 ± 0.51 
4 1.18 ± 0.04 2.72±1.12 6.48 ± 1.91 
5 1.46 ± 0.08 1.59 ± 0.35 6.54 ± 2.16 
6 1.49 ± 0.07 1.97 ± 0.34 6.28 ± 2.65 
7 1.36 ± 0.06 2.76 ± 1.06 5.06 ± 1.56 
8 1.51±0.12 3.54 ± 1.65 5.27 ± 2.44 
9 1.24 ± 0.23 3.77 ± 1.18 4.60 ± 1.49 
a Fold enrichment relative to whole homogenate. Values represent mean± SEM of 
three independent experiments. 
b Differential centrifugation fractions of whole homogenate: 
P1, S1, pellet and supernatant fractions, respectively, of700 g, 10 min. 
P2, S2, pellet and supernatant fractions, respectively, of 10,000 g, 20 min. 
P3, S3, pellet and supernatant fractions, respectively, of24,000 g, 20 min. 
c Percoll gradient fractions of P2. 
d Percoll gradient fractions of P3. 
Table 3. Percent recovery of marker enzyme activities in kidney fractions 
prepared by method 1 
Differential Centrifugation3 Percoll-Gradient 
Acid Phosphatase 76 ± 3.8 75 ± 5.5b 
Na+,K+ ATPase 74± 12.8 81 ± 11.0b 
Glucose-6-Phosphatase 86 ± 5.1 90 ± 1.2c 
Succinate Dehydrogenase 75 ± 4.9 79 ± 11 .8b 
a Recovery of activity in fractions P1,P2,P3 and S3 relative to activity in whole 
homogenate. Values represent mean± SEM of three independent experiments. 
b Recovery of total activity in Percoll gradients (fractions 1-9) relative to initial 
activity in P2. 
c Recovery of total activity in Percoll gradients (fractions 1-9) relative to initial 
activity in P3. 
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The distribution of enzyme activities in Percoll gradients is shown in Fig. 9. Acid 
phosphatase activity (Fig. 9A), exhibited a pronounced peak in fraction 1 (5.4-fold 
enrichment relative to whole homogenate), a small peak of activity was observed in 
fractions 8 and 9, enriched 3.42- and 3.15-fold, respectively. An enrichment of acid 
phosphatase in basolateral membrane fractions isolated from rat kidney cortex was 
reported by Inui et al. (1981) to be 1.3, with a recovery rate of 92.5%. The presence of a 
definite lysosomal peak in fraction 1 was attributed to the gentler resuspension procedure 
in method 2 (6 strokes) relative to method 1 (30 strokes). The smaller peak of activity in 
fractions 8 and 9 is probably due to vesicular trafficking. Further resolution of P2 on 
Percoll gradients yielded enrichment of succinate dehydrogenase in fractions 2-5; the 
enrichment factors were 4.43, 4.17, 3.84, and 4.01, respectively (Fig. 9B). Separation of 
lysosomes (Fig. 9A) from mitochondria could be attributed to the introduction of dense, 
2.4 M sucrose cushions. The relatively broad distribution of succinate dehydrogenase 
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Figure 8. Distribution of enzyme activities in kidney differential centrifugation fractions 
prepared by method 2. Differential centrifugation fractions were prepared by the 
procedures described in Fig. 2. Values represent the mean ± SEM, for (A) acid 
phosphatase specific activity (n=4); (B) succinate dehydrogenase specific activity (n=4); 
(C) alpha-D-mannosidase specific activity (n=3); (D) Na+,K+ ATPase specific activity 
(n=3); (E) glucose-6-phosphatase specific activity (n=3). Panel F indicates the results of 
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Figure 9. Distribution of enzyme activities in kidney Percoll gradient fractions prepared 
by method 2. Percoll gradient fractions were prepared by the procedures described in Fig. 
5. Values represent the mean± SEM, for (A) acid phosphatase specific activity (n=4); (B) 
succinate _ dehydrogenase specific activity (n=4); (C) alpha-D-mannosidase specific 
activity (n=3); (D) Na+,K+ ATPase specific activity (n=3); (E) glucose-6-phosphatase 
specific activity (n=3). Panel F indicates the results of protein distribution (n=5). 
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activity is in part due to the relatively shallow density changes in the mid region of these 
Percoll gradients (Nemere et al., 1986), and might also be due to heterogeneity in kidney 
mitochondria. 
The distribution of alpha-D-mannosidase specific activity is shown in Fig. 9C. Two 
peaks of activity were observed. The higher one was in fraction 1 (5.18-fold enrichment), 
while another small one was in fraction 8 (0.97-fold enrichment). Because acid 
phosphatase specific activity was highest in fraction 1, the alpha-D-mannosidase in the 
same fraction is most likely a lysosomal enzyme, whereas the smaller peak of 
mannosidase activity in fraction 8 represents the Golgi apparatus. The lighter density of 
the Golgi membranes was also seen for intestinal cells (Nemere eta!., 1986). 
Figure 9D shows that Na +, K+ ATPase specific activity was highest m gradient 
fraction 9 (enriched 7.34 fold), suggesting that this is the plasma membrane fraction. 
Sacktor et a!. (1981) reported that in rat renal basal lateral membrane vesicles, the 
enrichment of Na+,K+ ATPase assay was 11-fold, and recovery about 60%. Mircheff 
and Wright (1976) reported the enrichment ofNa+,K+ ATPase activity was 12-fold, and 
the recovery about 94%. Thus the current procedure yields a somewhat lower 
enrichment. 
Figure 9E reveals that the distribution of glucose-6-phosphatase specific activity was 
almost the same as that observed with method 1, except for a more pronounced enzyme 
activity peak in P3 Percoll gradient fraction 1. The enrichment factor was 13.5-fold 
relative to whole homogenates. The enrichment of glucose-6-phosphatase in plasma 
membrane fraction (P2, 9) was 3.99-fold, very close to the results of 3.2-fold 
enrichment, 97.8% recovery rate in kidney basal lateral plasma membrane vesicle 
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fraction reported by lnui et al. (1981). The profiles of protein distribution (Fig. 9F) 
suggest an almost equal level in each fractions of P2 or P3 Percoll gradient fractions, 
with the exception of high levels in P2, 2 and somewhat elevated levels in P2, 9 and P3, 9. 
Table 4 summarizes the data depicted in Figs. 8 and 9. Lysosomal acid phosphatase 
was mainly found in P2, 1 ( 5-fold), while 2- to 3-fold enrichment was found in fraction 7-
9, and may be due to vesicular trafficking. Plasma membrane fractions were localized 
near the top of the gradient, mitochondria in P2 Percoll gradient fractions 2-5, and Golgi 
membranes in fraction 8. Endoplasmic reticulum was enriched in fraction 1 of Percoll 
gradients prepared from P3. Recovery of marker enzyme activities in differential 
centrifugation fractions was found to be 85-100% of initial levels (Table 5). 
Approximately 90% recovery was found in Percoll gradient fractions, relative to levels 
in the original P2 or P3 pellet fractions . 
As noted above, method 1 did not achieve a separation of lysosomes from 
other components, as judged by the even distribution of acid phosphatase specific 
activity in all P2 Percoll gradient fractions. The plasma membrane fraction was 
determined to be P2, 9, the mitochondrial fraction was P2, 1, and the endoplasmic 
reticulum fraction was P3, 1. In method 2, lysosomes were in the P2, 1 fraction, the 
mitochondrial fractions were in P2, 2-5, Golgi membranes were in P2, 8, the plasma 
membrane fraction was in P2, 9, and the endoplasmic reticulum fraction was in P3, I. 
Enrichment factors for method 2 were either greater than for method 1 (acid 
phosphatase, 5.4 ± 0.58 vs 2.3 ± 0.4) or comparable (succinate dehydrogenase, 5 ± 2.5 
vs 4.4 ± 0.3; Na+, K+ ATPase, 15.4 ± 6.6 vs 7.3 ± 1.7; glucose-6-phosphatase, 8.97 ± 
2.42 vs 13 .5 ± 3.5). 
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Table 4. The enrichment of enzyme activities in kidney fractions prepared by method 2a 
Acid Succinate a-D- Na+,K+ Glucose-6-
Phosphatase Dehydrogenase Mannosidase ATPase Phosphatase 
PI b 0.97 ± 0.09 1.12 ± 0.06 0.36 ± 0.03 1.93 ± 0.42 0.91±0.10 
P2b 2.33 ± 0.59 2.46 ± 0.20 1.92 ± 0.24 2.07 ± 0.46 3.66±0.11 
P3b 0.53 ± 0.06 2.03 ± 0.40 0.02 ± 0.02 0.50 ± 0.09 4.85 ± 0.58 
s 1 b 1.23 ± 0.25 0.85 ± 0.04 1.62 ± 0.19 0.75 ± 0.24 1.74 ± 0.78 
S2b 0.95 ± 0.20 0.76±0.10 1.99 ± 0.15 0.26±0.15 0.86 ± 0.08 
S3b 0.64 ± 0.10 0.84±0.16 1.07 ± 0.10 0.06 ± 0.04 0.56 ± 0.22 
P2,1 c 5.40 ± 0.58 2.33 ± 0.55 5.18±0.83 0.82 ± 0.50 5.86 ± 0.86 
2 1.10 ± 0.07 4.43 ± 0.30 1.08 ± 0.11 0.65 ± 0.32 2.32 ± 0.14 
3 1.73 ± 0.47 4.17 ± 0.59 0.79±0.13 0.69±0.12 4.71 ± 0.98 
4 1.87 ± 0.29 3.84 ± 0.99 0.68 ± 0.12 0.64 ± 0.36 6.66 ± 1.06 
5 1.88 ± 0.25 4.01 ± 0.83 0.32±0.15 0.38 ± 0.20 7.57 ± 0.93 
6 1.96 ± 0.27 3.03 ± 0.89 0.30±0.13 1.15±0.55 7.85 ± 0.56 
7 2.49 ± 0.32 2.60 ± 0.53 0.35 ± 0.09 1.40 ± 0.46 6.70 ± 0.13 
8 3.42 ± 0.70 1.93 ± 0.41 0.97 ± 0.26 3.27±0.16 6.29 ± 0.50 
9 3.15 ± 0.74 0.93±0.18 0.56 ± 0.05 7.34 ± 1.73 3.99 ± 0.16 
P3, I ct 13.50± 3.48 
2 9.36 ± 1.30 
3 7.73 ± 1.02 
4 6.86± 1.16 
5 7.46 ± 1.2 
6 6.34 ± 0.91 
7 5.85 ± 0.94 
8 5.68 ± 0.57 
9 5.08 ± 0.56 
a Fold Enrichment relative to whole homogenate. Values represent mean± SEM of 
three independent experiments. 
b Differential centrifugation fractions of whole homogenate: 
PI, s~, pellet and supernatant fractions, respectively, of 700 g, 10 min; 
P2, S2, pellet and supernatant fractions, respectively, of24,000 g, 20 min; 
P3, S3, pellet and supernatant fractions, respectively, of 100,000 g, 60 min. 
c Percoll gradient fractions of P2. 
d Percoll gradient fractions of P3. 
Table 5. Percent recovery of marker enzyme activities in kidney fractions 
prepared by method 2 
Differential Centrifugationa Percoll-Gradient 
Acid Phosphatase 86 ± 3.4 91 ± 2.9b 
Na+,K+ ATPase 83 ± 8.9 93 ± 2.9b 
Glucose-6-Phosphatase 94 ± 3.4 94 ± 1.4c 
Succinate Dehydrogenate 97 ± 2.9 93 ± 3.2b 
a-D-Mannosidase 93 ± 2.6 88 ± 2.3b 
a Recovery of activity in P1, P2, P3 and S3 relative to activity in whole homogenate. 
Values represent mean± SEM ofthree independent experiments. 
b Recovery of total activity in Percell gradients( fractions 1-9) relative to initial 
activity in Pz. 
c Recovery of total activity in Percell gradients( fractions 1-9) relative to initial 
activity in P3. 
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The recovery of enzyme activities usmg method 1 was 72-90% in differential 
centrifugation fractions, and approximately 80% in Percoll gradient fractions. In method 
2, recoveries were 85-100% and 90%, respectively, for differential and Percell gradient 
centrifugation fractions. Thus the recoveries of enzyme activities in method 1 were lower 
than those in method 2. 
Distribution of Marker Enzyme Activities in 
Brain Fractions Prepared by Method 1 
Figure 10 illustrates the distribution of marker enzyme activities and protein in 
differential centrifugation fractions of chick brain prepared by method 1. Acid 
phosphatase (Fig. 1 OA) and succinate dehydrogenase (Fig. 1 OB) activities were enriched 
in fraction P2, 1.47- and 2.14-fold, respectively, above corresponding levels in whole 
homogenates; Na+,K+-ATPase (Fig. 10C) was enriched somewhat over 2-fold in both P1 
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Figure 10. Distribution of enzyme activities in brain differential centrifugation fractions 
prepared by method 1. Differential centrifugation fractions were prepared by the 
procedures described in Fig. 4. Values represent the mean ± SEM, for the following 
specific activities, (A) acid phosphatase (n=4); (B) succinate dehydrogenase (n=3); (C) 
Na +,K+ ATPase (n=4); (D) glucose-6-phosphatase (n=4). Panel E indicates the results of 
protein distribution (n=4). 
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and P2. While glucose-6-phosphatase (Fig. I OD) was enriched I.8- fold in P2, the activity 
was present in all fractions tested. 
Figure II depicts the distribution of these marker enzyme activities and protein in P2 
Percoll gradients prepared by method I. Acid phosphatase (Fig. IIA), Na+,K+-ATPase 
(Fig. II C), and glucose-6-phosphatase (Fig. II D) activities were enriched in the top 
fractions, 2.I-, 3 .5-, and 4-fold, respectively, relative to corresponding levels in whole 
homogenates. Succinate dehydrogenase was enriched 2-fold in fractions I-3 (Fig. 1I B). 
The protein distribution, shown in Fig. II E, reveals nearly equilvalent levels in each P2 
Percoll gradient fraction except P2, 1 and 9. Fraction P2, I had the highest protein level. 
Table 6 summarizes the enrichment data in brain fractions prepared by method 1. 
Table 7 shows the recovery of marker enzyme activities in brain fractions prepared 
by method I. The recovery of enzyme activities in differential centrifugation fractions 
was 60-90%, relative to the corresponding activity in whole homogenates. In Percoll 
gradient fractions, the recovery was 77-85%, relative to the initial corresponding activity 
Distribution of Marker Enzyme Activities in 
Brain Fractions Prepared by Method 2 
The distribution of marker enzyme activities in differential centrifugation fractions of 
brain is shown in Fig. I2. Acid phosphatase activity (Fig. I2A) failed to show an 
enrichment over whole homogenate, most likely because the samples were frozen prior to 
assay, thus destroying the cold-sensitive enzyme. Succinate dehydrogenase (Fig. I2B) 
and Na+,K+-ATPase activity (Fig. I2D) were each enriched 2-fold in P2, whereas alpha-
D-mannosidase (Fig. I2C) was not enriched in any fraction. Glucose-6-phosphatase was 
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Figure 11. Distribution of enzyme activities in brain Percoll gradient fractions of P2 
prepared by method 1. Percoll gradient fractions were prepared by the procedures 
described in Fig. 3. Values represent the mean ± SEM, for the following specific 
activities, (A) acid phosphatase (n=4); (B) succinate dehydrogenase (n=3); (C) Na+,K+ 
A TPase (n=4 ); (D) glucose-6-phosphatase (n=4 ). Panel E indicates the results of protein 
distribution (n=4). 
Table 6. Enrichment of enzyme activities in brain fractions prepared by method 1 a 
Acid Phosphatase Succinate Na+,K+ ATPase Glucose-6-
Dehydrogenase Phosphatase 
plb 0.48 ± 0.08 1.35±0.31 2.26 ± 0.68 1.37±0.31 
p2b 1.47 ± 0.20 2.14 ± 0.25 2.55 ± 0.42 1.82 ± 0.62 
s1b 0.83 ± 0.10 0.61 ± 0.32 1.63 ± 0.32 0.97 ± 0.10 
s2b 0.74 ± 0.08 0.65 ± 0.21 0.88±0.15 0.83 ± 0.09 
P2, 1 c 0.85 ± 0.08 2.17 ± 1.02 1.23±0.13 1.08 ± 0.24 
2 1.04 ± 0.20 1.98 ± 0.36 1.52 ± 0.34 1.43 ± 0.43 
3 0.88 ± 0.07 1.73 ± 0.30 1.63 ± 0.38 2.15±1.01 
4 1.02 ± 0.03 1.34 ± 0.18 1.87 ± 0.62 1.90 ± 0.85 
5 0.72 ± 0.07 1.47 ± 0.20 2.21 ± 0.45 1.87 ± 0.52 
6 0.85 ± 0.01 1.23 ± 0.33 2.11 ± 0.31 2.09 ± 0.66 
7 1.11 ±0.10 1.21 ±0.17 2.71±0.82 1.75 ± 0.71 
8 2.13±0.35 1.37 ± 0.26 3.47 ± 0.60 2.75 ± 0.94 
9 2.07 ± 0.49 0.89 ± 0.18 3.30 ± 0.62 3.98 ± 1.17 
a Fold enrichment relative to whole homogenate. Values represent mean± SEM of3 
independent experiments. 
b P 1, S1, pellet and supernatant fractions respectively of differential centrifugation at 
1000 g, 10 min. P2, S2, pellet and supernatant fractions respectively of differential 
centrifugation at 10,000 g, 20 min. 
c Percoll gradient fractions of P2. 
Table 7. Percent recovery of marker enzyme activities in brain fractions 
prepared by method 1 
Differential Percoll-Gradient 
Centrifugation a 
Acid Phosphatase 65 ± 4.0 77 ± 1.8b 
Na+,K+ ATPase 59± 5.8 79 ± 5.3b 
G1ucose-6-Phosphatase 88 ± 4.5 85 ± 2S 
Succinate Dehydrogenase 79 ± 9.2 78 ± 4.6b 
a Recovery of activity in fractions P 1,P2, and S2 relative to activity in whole 
homogenate. Values represent mean ± SEM of three independent experiments. 
b Recovery of total activity in Percoll gradients (fractions 1-9) relative to initial 
activity in P2. 
c Recovery of total activity in Percoll gradients (fractions 1-9) relative to initial 
activity in P3. 
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Figure 12. Distribution of enzyme activities in brain differential centrifugation fractions 
prepared by method 2. Differential centrifugation fractions were prepared by the 
procedures described in Fig. 4. Values represent the mean ± SEM, for the following 
specific activities, (A) acid phosphatase (n=4); (B) succinate dehydrogenase (n=3); (C) 
alpha-D-mannosidase (n=3); (D) Na+,K+ ATPase (n=4); (E) glucose-6-phosphatase 
(n=3). Panel F indicates the results of protein distribution (n=4). 
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found to be enriched 2-fold in P3. Only the P2 fraction was chosen for further resolution 
on Percoll gradients, as shown in Fig. 13 . 
In Percoll gradients, acid phosphatase exhibited a peak in fractions 1 and 8-9 (Fig. 
13A). Enrichment for each was approximately 1.5-fold over whole homogenates. In 
analogy to the results with kidney, fraction 1 was identified as lysosomes, and the less 
dense peak as Golgi, or endocytic vesicles. The activity of succinate dehydrogenase (Fig. 
13B) was enriched 8-fold in fractions 2-5 . 
The distribution of Alpha-D-mannosidase activity, a marker enzyme for both 
Lysosomes and Golgi apparatus, is shown in Fig. 13C. The pellet fraction P2 revealed 
two peaks of activity in Percoll gradients: fraction 1(3.43 fold enrichment) was much 
higher than fraction 8 (1.63 fold enrichment). Since fraction 1 was the lysosomal fraction, 
fraction 8 most likely representes the Golgi fraction. Resolution of P2 on Percoll gradients 
yielded a peak ofNa+,K+-ATPase, P2, 9 (enriched 4.87-fold) (Fig. 13D); Percoll gradients 
of P3 clearly revealed the highest activities of glucose-6-phosphatase in fractions 1-3 
(Fig. 13E). Protein profiles are presented in Fig. 13F for both P2 and P3. The fractions 
that are close the top of centrifugation tubes (8-1 0) have higher protein concentrations. 
Table 8 summarizes the enrichment of enzyme activities relative to the corresponding 
activity in whole homogenates of brain fractions prepared by method 2. Acid phosphatase 
was enriched 1.6-fold in P2, 1; succinate dehydrogenase, 8-fold in P2, 2-5; alpha-D-
mannosidase, 3-fold in fraction 1, and 1.6-fold in fraction 8; Na+, K+ ATPase, 5-fold in 
P2, 9; glucose-6-phosphatase, 20- to 23-fold in P3, 1-3 . The recovery of enzyme activities 
is presented in Table 9. The recoveries of enzyme activities in differential centrifugation 
fractions were 86-98%, relative to the activities in the whole homogenate. In Percoll 
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Figure 13. Distribution of enzyme activities in brain Percoll gradient fractions of P2 and 
P3 (for glucose-6-phosphatase) prepared by method 2. Percoll gradient fractions were 
prepared by the procedures described in Fig. 5. Values represent the mean± SEM, for the 
following specific activities, (A) acid phosphatase (n=4); (B) succinate dehydrogenase 
(n=3); (C) alpha-D-mannosidase (n=3); (D) Na+,K+ ATPase (n=4); (E) glucose-6-
phosphatase (n=3). Panel F indicates the results of protein distribution (n=4). 
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Table 8. The enrichment of enzyme activities in brain fractions prepared by method 23 
Acid Succinate a-D- Na+,K+ Glucose-6-
Phosphatase Dehydrogenas Mannosidase ATPase Phosphatase 
e 
PI 0.71 ± 0.06 1.07±0.13 0.36 ± 0.07 1.78 ± 0.34 0.79 ± 0.09 
p 2b 0.76 ± 0.12 2.11 ± 0.21 0.70±0.17 3.65 ± 0.30 1.99 ± 0.26 
p 3b 0.46 ± 0.02 0.53 ± 0.32 0.36 ± 0.03 1.01 ± 0.04 2.38 ± 0.07 
sib 0.64 ± 0.08 1.19 ± 0.21 0.89±0.16 1.30 ± 0.40 0.52 ± 0.12 
s 2b 0.42 ± 0.05 1.27 ± 0.29 0.65 ± 0.28 0.48 ± 0.27 0.40 ± 0.08 
s 3b 0.28 ± 0.02 0.45 ± 0.26 0.37 ± 0.07 0.65 ± 0.06 0.33 ± 0.03 
P 2, 1 c 1.57 ± 0.41 6.13 ± 0.55 3.43 ± 0.51 1.44 ± 0.13 11.73 ± 1.41 
2 0.92 ± 0.12 8.26 ± 1.18 1.99 ± 0.28 1.29 ± 0.33 4.87 ± 0.28 
3 0.55 ± 0.09 8.21 ± 1.06 1.65 ± 0.69 1.65 ± 0.30 4.78 ± 0.51 
4 0.50 ± 0.18 8.14 ± 0.95 0.12±0.03 1.61 ± 0.29 5.40 ± 0.86 
5 0.41 ±0.15 7.99 ± 1.14 0.50 ± 0.92 2.49 ± 0.47 5.85 ± 1.27 
6 0.61±0.17 6.33 ± 0.72 0.30 ± 0.10 1.52 ± 0.40 4.00 ± 0.87 
7 0.92 ± 0.23 3.14 ± 0.42 0.76 ± 0.36 1.92 ± 0.41 2.73 ±0.61 
8 1.46 ± 0.27 1.89±0.15 1.63 ± 0.35 2.44 ± 0.31 1.49 ±0.16 
9 1.33±0.16 1.11 ± 0.25 0.40 ± 0.27 4.87 ± 0.36 1.62 ± 0.24 
10 1.05 ± 0.12 0.89 ± 0.21 0.11 ± 0.05 1.83 ± 0.20 
P 3, I 
d 
21.07±3 .17 
2 23.39 ± 1.34 
3 20.47 ± 0.17 
4 16.89 ± 2.59 
5 12 .37 ± 4.22 
6 10.69 ± 2.92 
7 5.84 ± 1.47 
8 2.55 ± 0.32 
9 1.96 ± 0.74 
10 1.56 ±0.14 
a Fold enrichment relative to whole homogenate. Values represent mean± SEM of 
three independent experiments. 
b Differential centrifugation fractions of whole homogenate: 
P1, S1, pellet and suspernatant fractions, respectively, of 1000 g, 10 min. 
P2, S2, pellet and supernatant fractions, respectively, of 10,000 g, 20 min. 
P3, S3, pellet and supernatant fractions, respectively, of 100,000 g, 60 min. 
c Percoll gradient fractions of P2. 
d Percoll gradient fractions of P3. 
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gradient fractions, the recoveries were 83-99% relative to initial activities in P2, or P3 
for glucose-6-phosphatase. 
In method 1, the enzyme activity peaks of acid phosphatase and Na+, K+ ATPase 
were in the same fraction (P2, 9). So this method did not separate lysosomes and plasma 
membranes. In method 2, separation was achieved among lysosomes (P2, 1 ), 
mitochondria (P2, 2-5), Golgi (P2, 8), plasma membrane (P2, 9 and 1 0), and 
endoplasmic reticulum (P3, 1-3). The recovery in method 2 was higher than that in 
method 1, for both differential centrifugation and Percoll gradient fractions . The 
enrichment for acid phosphatase activity was comparable for methods 1 and 2 (2.1 ± 0.5 
vs 1.6 ± 0.4), whereas enrichment in method 1 versus method 2 was lower for succinate 
dehydrogenase (2.17 ± 1.02 vs 8.2 ± 1.2), Na+, K+-ATPase (3.5 ± 0.6 vs 4.9 ± 0.4), and 
glucose-6-phosphatase (4.0± 1.2 vs 23 ±1.3). 
In conclusion, method 2 was found to be superior for organelle separation, in both 
brain and kidney. The reasons probably include: ( 1) In method 1, P2 is resuspended by 
homogenization in a Teflon-glass homogenizer with 30 strokes (kidney), or 25 strokes 
(brain), whereas in method 2, both were homogenized with 6 strokes. In method 1, it is 
likely that some organelles were damaged, especially lysosomes, thereby changing 
their buoyant density. This may be an important reason why method 1 cannot 
separate lysosomes from other fractions very well. (2) In method 1, the Percoll 
concentration used in the density gradients was 8% (starting density below 1.04). In 
method 2, gradients contained 22% Percoll, allowing formation of steeper density 
changes. Thus fractions prepared by method 2 were used for SDS-PAGE and Western 
blots. 
Table 9. Percent recovery of marker enzyme activities in brain fractions prepared 
by method 2a 
Differential Centrifugationa Percoll-Gradient 
Acid Phosphatase 86 ± 5.5 83 ± 2.4b 
Na+,K+ ATPase 95 ± 4.1 93 ± 1.6b 
Glucose-6-Phosphatase 98 ± 5.0 99 ± 4.4° 
Succinate Dehydrogenate 96 ± 1.5 95 ± 1.4b 
u-D-Mannosidase 86 ± 2.1 80 ± 2.8b 
a Recovery of activity in P1, P2, S2 relative to activity in whole homogenate. 
Values represent mean ± SEM of three independent experiments. 
b Recovery of total activity in Percell gradients (fractions 1-9) relative to initial 
activity in P2. 
c Recovery of total activity in Percell gradients (fractions 1-9) relative to initial 
activity in P3. 
SDS-PAGE and Western Blot Analysis 
Kidney 
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Figures 14 and 15 show the Coomassie staining of SDS-PAGE gels of chick kidney 
differential centrifugation and Percell gradient fractions, respectively. Many protein 
bands can be observed in each fraction. In contrast, only one band is apparent upon 
Western analysis (Fig. 16). Western analysis as a function of protein concentration (Fig. 
16) demonstrated increasing band density to 20 ug/well. In order to monitor relative 
differences, subsequent gels and Westerns were analyzed using 1 0 ug of kidney protein 
per well. A representative Western analysis of kidney differential centrifugation fractions 
with antibody 099 against the basal lateral membrane receptor for 1 ,25(0H)2 D3 (BLM-
VDR) in chick intestine is shown in Fig. 17. In order to analyze the results quantitatively, 



















Figure 14. SDS-PAGE of chick kidney differential centrifugation fractions: protein 
staining. The kidney differential centrifugation fractions were obtained by the procedures 
described in the legend to Fig. 3. After SDS-PAGE electrophoresis (using 100 IJ.g 
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Figure 15. SDS-PAGE of chick kidney Percoll gradient fractions: protein staining. The 
kidney P2 Percoll gradient fractions were obtained by the procedures described in the 
legend to Fig. 6. After SDS-PAGE electrophoresis (using 100 11g protein/well), 
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Figure 16. Western analysis of chick kidney P2 pellet: protein dependence. Chick 
kidney P2 differential centrifugation fraction were subjected to SDS-PAGE. The protein 
concentrations tested were 5, 10, 15, 20, 25, 30 IJ.g/well as indicated. Electro blotting 
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Figure 17. Western analysis of chick kidney differential centrifugation fractions with 
Ab099. The kidney differential centrifugation fractions were obtained from the 
procedures described in Fig. 2. After SDS-PAGE (10 IJ.g protein/well), electro-blotting 
was performed at 10 volts, 4°C for 13 h, followed by Western blot analysis of proteins on 
the PVDF membrane. Primary antibody to chick BLM-VDR was used at a 1 :5000 
dilution, and the alkaline phosphatase-conjugated secondary antibody was used at 
1:30,000 dilution. Supernatant fractions (S 1, S2, S3) are compared with pellet fractions 
(Ph P2) and whole homogenate (Po). 
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software program (Dendron 2.0). For comparison between experiments, band densities 
for each fraction were expressed as a ratio to Po (whole homogenate). Figure 18 
summarizes the results. The P2 pellet contained the highest 1 ,25(0H)2D3 receptor 
antigenicity. Percell gradient fractions of P2 were then subjected to Western analyses 
with Ab099 (Fig. 19) and the blots densitometrically quantitated (Fig. 20). The highest 
densities for receptor antigenicity were in fractions P2, 6-9. 
Specific eHJ 1 ,2S(OH)2D3 binding was assessed in P2 fractions of replicate 
experiments. Fractions 1-5 either had no specific binding or higly variable binding. 
Specific binding in fractions 6, 7, 8, and 9 was, respectively, 34 ± 5, 33 ± 20, 32 ± 2, 
and 49 ± 15 fmols/mg protein (Table 1 0). 
Brain 
Fig. 21 shows the Coomassie protein staining of SDS polyacrylamide gels of chick 
brain differential centrifugation-, and P2 percoll gradient-fractions. Once again, many 
protein bands can be seen in each fraction . Protein dependence of chick brain P2 pellet 
fraction on Western analysis is shown in Fig. 22. Reactive bands demonstrated increasing 
intensity with increasing protein concentration. For subsequent analyses, 25 !J.g/well was 
chosen for the protein concentration. 
Figures 23 and 24 illustrate the results of SDS-PAGE and Western blot analyses of 
brain differential centrifugation fractions: The receptor antigen was not enriched over 
whole homogenate in any particular fraction. Figures 25 and 26 show the Western 
analysis of chick brain P2 percoll gradient fractions with Ab099. The receptor antigen 
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Figure 18. Relative distribution of receptor antigen in differential centrifugation 
fractions prepared from kidney by method 2. The Western blots, including that in Fig. 17, 
were scanned into a computer file, and densitometrically analyzed using Dendron 
softwware. In order to normalize values between experiments, band densities for each 
fraction were expressed as a ratio to Po (whole homogenate). Values represent mean ± 
SEM of three independent experiments. 
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Figure 19. Western analysis of chick kidney P2 Percoll gradient fractions with Ab099. 
Fractions were obtained from the procedures described in Fig. 5. After SDS-PAGE (10 
j.!g protein/well), electroblotting was performed at 10 volts, 4°C for 13 h, followed by 
Western blot analysis of proteins on the PVDF membrane. Primary antibody to chick 
BLM-VDR was at a 1:5000 dilution, and the alkaline phosphatase-conjugated secondary 
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Fractions 
Figure 20. Relative distribution of receptor antigen in P2 Percell gradient fractions 
prepared from kidney by method 2. The Western blots, including that in Fig. 19., were 
scanned into a computer file, and blots densitometrically analyzed using Dendron 
softwwere. In order to normalize values between experiments, band densities for each 
fraction were expressed as a ratio to Po (whole homogenate). Values represent mean ± 
SEM of three independent experiments. 
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Figure 21. SDS-PAGE of chick brain fractions : protein staining. The brain differential 
centrifugation and P2 Percoll gradient fractions were obtained by the procedures 
described in the legend to Figs. 4 and 5. After SDS-PAGE (using 100 ~g protein/well), 
Coomassie staining and destaining were performed. 
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Figure 22. Western analysis of chick brain P2 pellet: protein dependence. Chick brain P2 
differential centrifugation fraction were subjected to SDS-PAGE using protein 
concentrations that were 5, 10, 15, 20, 25, 30 Jlg/well as indicated. Electroblotting and 











Figure 23. Western analysis of chick brain differential centrifugation fractions with 
Ab099. The brain differential centrifugation fractions were obtained from the procedures 
described in the legend to Fig. 4. After SDS-PAGE (25 J.lg protein/well), electroblotting 
was performed at 1 0 volts, 4 °C for 13 h, followed by Western blot analysis of proteins 
on PVDF membrane. Primary antibody to chick BLM-VDR was at a 1:5000 dilution, 























Figure 24. Relative distribution of receptor antigen in differential centrifugation 
fractions prepared from brain by method 2. The Western blots, including that in Fig. 23 , 
were scanned into a computer file, and densitometrically analyzed using Dendron 
software. In order to normalize values between experiments, band densities for each 
fraction were expressed as a ratio to Po (whole homogenate). Values represent mean ± 
SEM of three independent experiments. 
1 2 3 4 5 6 
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Figure 25. Western analysis of chick brain P2 Percell gradient fractions with Ab099. 
The brain Pz Percell gradient fractions were obtained from the procedures described in 
the legend to Fig. 5. After SDS-PAGE (25 1-J.g protein/well ), electroblotting was 
performed at 10 volts, 4°C for 13 h, followed by Western blot analysis of proteins on 
PVDF membrane. Primary antibody to chick BLM-VDR was at a 1:5000 dilution, and 
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Fractions 
Figure 26. Relative distribution of receptor antigen in P2 Percoll gradient fractions 
prepared from brain by method 2. The Western blots, including that in Fig. 25, were 
scanned into a computer file, and densitometrically analyzed using Dendron software. In 
order to normalize values between experiments, band densities for each fraction were 
expressed as a ratio to Po (whole homogenate). Values represent mean± SEM of three 
independent experiments. 
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fractions of replicate experiments again revealed highly variable binding in fractions 1-6. 
Fractions 7, 8, and 9 specifially bound CHJ1,25(0H)2D3 at 16 ± 7, 13 ± 3, and 23 ± 6 
fmols/mg protein, respectively (Table 1 0). From Table 10, in kidney, P2, 6-9 fractions 
and in brain, P2, 7-9 fractions both have definite receptor CHJ1,25(0H)2D3 binding 
activities, suggesting these plasma membrane receptors are functional, but the binding 
values in kidney are much higher than the binding values of corresponding brain 
fractions, indicating there is a stronger receptor activity in kidney than brain. 
Western analyses of plasma membrane fractions from chick kidney, brain, and 
intestine with Ab099 were undertaken (Fig. 27). Visually, kidney receptor staining 
intensity was slightly greater or equivalent to levels in intestine, while whole brain 
contained notably less antigenicity. 
Table 10. Specific CHJ 1 ,25(0H)2D3 binding in kidney and brain P2 
and P2 Percoll gradient fractions. a 
Kidney (fmols/mg protein) Brain (fmols/mg protein) 
p2b 









10.00 ± 8.00 
9.60 ± 9.60 
4.20 ± 21.00 
-64.00 ± 91.00 
-6.00 ± 12.00 
-2.00 ± 2.00 
34.42 ± 5.11 
32.54 ± 20.12 
32.28 ± 2.28 
48.51 ± 14.79 
53.47 ± 11.47 
47.28 ± 27.46 
10.12 ± 10.12 
14.95 ± 11.00 
24.00 ± 24.00 
0.00 ± 0.00 
7.00 ± 7.00 
16.26 ± 6.65 
12.71 ± 3.22 
23.09 ± 6.00 
a Values represent mean ± SEM of two independent experiments. 
b P2 differential centrifugation fraction. 











Figure 27. Western analysis of plasma membranes from chick kidney, brain, and 
intestine with Ab099. Plasma membrane fractions of these three tissues were used to run 
SDS-PAGE (25 J.lg protein/well). Electroblotting was performed, followed by western 
blot analysis of proteins on the PVDF membrane. Primary antibody to chick BLM-VDR 
was at a 1:5000 dilution, and the alkaline phosphatase-conjugated secondary antibody 
was used at 1 :30,000 dilution. ( K: kidney, B: brain, I: intestine ). 
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In kidney, fractions 6 and 7 do not contain any organelle marker enzyme, but show 
receptor activity, especially fraction 7. It is possible that these fractions contain 
trafficking vesicles, which come from the plasma membrane, and have the 1 ,25(0H)2D3 
receptor or 1,25(0H)2D3 -receptor complex. Fraction 8 is the Golgi fraction; it contains 
the plasma membrane which is brought there by vesicles, so it is not surprising that this 
fraction also has high receptor activity. We still do not know the physiological meaning 
and the mechanism of action of these membrane receptors. One possibile mechanism of 
action is that 1 ,25(0H)2D3 is bound with the receptors and then packaged in vesicles, 
which can travel inside the cell, while causing a reaction cascade. It is possible that after 
some kind of modification, the receptor-ligand complex can get into the nucleus and lead 
to genome regulation, just like nuclear receptors (Barinaga, 1997). Another possibility is 
that the combining of 1,25(0H)2D3 with the membrane receptor itself causes a signal 
cascade, activating a series of enzymes and producing the physiological action. This 
mechanism provides a much more rapid response than with nuclear receptors and may 
mediate reabsorption of calcium in the kidney tubule. 
In brain, specific eHJ 1 ,2S(OH)2D3 binding indicates fraction P2, 7 has receptor 
activity apparently equivalent to that of fraction 8, but less than that of fraction 9. 
Western blots show that most of the receptor antigenilty is in P2,8 and 9. The differences 
may be due to the technical difficulties in the eHJ 1 ,2S(OH)2D3 binding assay. Fraction 
P2,1 exhibited highly variable binding (4.68 and 2.72 fmols/0 .2 ml) perhaps due to low 
protein levels. However, there does appear to be binding activity in lysosomes. The exact 
function of the 1,25(0H)2D3 receptors in brain cells is not clear so far. They may be 
67 
involved in cell proliferation and differentiation, or may mediate the rapid input of 
calcium to facilitate neurotransmitter release. 
In conclusion, in this project, we designed two sets of protocols to isolate the plasma 
membrane fractions from kidney and brain whole homogenate and found method 2 to be 
superior to method 1; using differential centrifugation, Percoll gradient centrifugation, 
and enzyme assays, the distribution of organelles in kidney and brain was established. 
Plasma membrane receptors for 1 ,25(0H)2D3 were found in both chick kidney and 
brain cells, and they are both functional, although the receptor activity in brain is much 
lower than that in kidney. The physiological functions and the mechanisms of action of 
these membrane receptors still need to be determined. 
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